XLV Stock Recent News

Nonfarm payrolls increased by 254, 000 jobs in September, the most since March.

Total S&P 500 earnings are expected to be up 3.7% from the year-ago period on 5.1% higher revenues. Of the 16 Zacks sectors, nine are expected to post earnings growth.

I am bullish on the Health Care Select Sector SPDR ETF (XLV) due to its attractive valuation, strong technical setup, and favorable seasonality heading into Q4. Eli Lilly (LLY) is a standout component, contributing significantly to XLV's valuation, but the ETF remains appealing even when backing out LLY's high P/E ratio. XLV offers diversified exposure across various healthcare industries, with significant holdings in large-cap stocks like UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and Merck (MRK).

Chris Verrone, Strategas head of technical and macro research, joins 'Fast Money' to give his health care playbook.

When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.

With the markets recently experiencing a sharp sell-off which may have dampened investor confidence, increasing bets that the U.S. economy may slip into a recession increases the need to safeguard investor portfolios with defensive bets.

The chart of the Health Care Select Sector SPDR Fund  XLV offers two valuable technical analysis lessons.

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Health Care Select Sector SPDR ETF (XLV), a passively managed exchange traded fund launched on 12/16/1998.

The healthcare sector has gained momentum lately on market rotation, with investors rushing to buy beaten-down stocks while shunning the hot technology sector.

Compelling valuation, innovation in specific growth areas and an aging population as well as increasing healthcare spending are the tailwinds of the medical sector.